Versicor (VERS) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Versicor (VERS)

An SI Board Since August 2000

Posts	SubjectMarks	Bans	Symbol
83	9	0	MICU

Emcee: sim1	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
58	Something is up....beginning yesterday we had several block trades. Already this	Arthur Radley	-	12/12/2003
57	Milestone payment and new Phase I test with Novartis announced this morning...	Arthur Radley	-	12/4/2003
56	Hadn't looked here in a while. Interesting to see micafungin might have dru	tuck	-	11/17/2003
55	MICU: 3Q03 Results; Raising Price Target Ahead of Near-Term Clinical & Regul	Arthur Radley	-	11/16/2003
54	This from the Houston Chronicle today and why we need new antibotics from MICU a	Arthur Radley	-	11/1/2003
53	Just hit new 52 week high...Could it be!!!	Arthur Radley	-	10/29/2003
52	From page article and sports page article in today's USA Today is very scary	Arthur Radley	-	10/15/2003
51	Positive news release this morning, with milestone payment from Novartis. I pur	Arthur Radley	-	9/4/2003
50	Company says data is positive, but the stock dropped a bit after release of this	tuck	-	5/12/2003
49	At least it works in mice... biz.yahoo.com	Arthur Radley	-	5/12/2003
48	Vicuron Submits New Drug Application for Anidulafungin to FDA KING OF PRUSSIA,	nigel bates	-	4/28/2003
47	Dr. Garren added another 1000 shares of MICU to his model portfolio today...and	Arthur Radley	-	3/31/2003
46	Tuck, I think the name change was part of the arrangement in the merger with the	Arthur Radley	-	3/31/2003
45	Thought folks might like to know BioSpace's Dr. Garren likes VERS -- now MIC	tuck	-	3/30/2003
44	Might as well post the trial results for comparisons . . . >>KING OF P	tuck	-	3/19/2003
43	The clinical goods on Cancidas, approved for refractory IA: cancidas.com Here&	tuck	-	3/19/2003
42	NEW YORK -- Despite positive data, Versicor Inc.'s antifungal agent, anidula	nigel bates	-	3/19/2003
41	Texas Dude--Thank you. I listened to the conference call and they said the same	JOEBT1	-	3/17/2003
40	Joe, This latest release seems to better speak to this issue..... "There s	Arthur Radley	-	3/17/2003
39	Joe, The primary endpoint is "okay" IMO....especially when you have a	Arthur Radley	-	3/17/2003
38	Texas Dude-The data for the PIII trial just released doesn't compare very we	JOEBT1	-	3/17/2003
37	Not that VERS has the solution to this problem, but the world news isn't goo	Arthur Radley	-	3/16/2003
36	Activity today...indicates that news is just around the corner on the Phase III	Arthur Radley	-	3/12/2003
35	For those who apply TA to their investing..VERS moved above the 50 Day and 200 D	Arthur Radley	-	3/5/2003
34	VERS sitting as number 2 selection of highest analyst rated stocks as listed by	Arthur Radley	-	3/4/2003

Go to reply# or date (mm/dd/yy):